May 2012 Editor's Picks: Products from Koslow Scientific Company and Vaisala - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

May 2012 Editor's Picks: Products from Koslow Scientific Company and Vaisala

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

Koslow Scientific Company
Portable tester verifies passivation of stainless-steel equipment

Koslow Scientific Company’s Passi-Flash 3036 portable instrument for passivation testing works with all grades of stainless steel to verify that vessels, piping, and equipment are free from iron particles that can oxidize and contaminate products. The tester resembles an oversized pen and is designed for single-handed operation. It produces a pass/fail signal in less than one second and displays the measurement in millivolts. The built-in memory stores readings for download to a record-keeping system. Portable testers allow users to test equipment on-site, rather than at an outside testing facility, notes the company.


Vaisala
Cold chain logger records time and temperature data

Vaisala’s CCL100 Cold Chain Logger records and monitors time and temperature during transportation of vaccines, pharmaceuticals, biologics, and other perishable products. The thin, compact, single-use sensor can be placed inside or on top of a package where it reads and records surface temperature throughout the cold chain. The new logger is in a sealed, waterproof package that is smaller than existing packages. The logger features a simple delivery system that does not require special readers or software, but connects to a USB port to generate a comprehensive report of the package’s history. A flashing LED on the logger alerts operators to any temperature excursions.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Equipment and Processing Report,
Click here